Healthcare Realty Trust (HR) has successfully concluded the first year of its ambitious strategic plan, reporting impressive financial results for the second quarter of 2026. The company's focused efforts on operational excellence, portfolio enhancement, and strategic capital deployment have yielded significant gains, including a notable increase in Normalized Funds From Operations (FFO) per share and strong Same Store Cash Net Operating Income (NOI) growth. These achievements highlight the effectiveness of their renewed approach in a dynamic market environment.
During the second quarter of 2026, Healthcare Realty Trust demonstrated robust financial performance, with Normalized FFO reaching $0.41 per share. This was largely propelled by exceptional property operations and a series of successful leasing activities within its medical office portfolio. The Same Store Cash NOI experienced a substantial year-over-year increase of 5.1%, reflecting significant occupancy gains and high tenant retention rates. Looking forward, the company has raised its Normalized FFO guidance to a range of $1.62 to $1.66 per share, an increase of $0.02 at the midpoint from earlier projections, signaling sustained confidence in its financial trajectory. Furthermore, Same Store Cash NOI growth guidance has been adjusted upwards to 4.3% to 5.0%, driven by positive leasing momentum. Despite these successes, the GAAP Net Loss stood at $0.13 per share, primarily due to a $42.7 million charge related to real estate impairment during the quarter. The company executed 1.5 million square feet in leases, boasting a weighted average lease term of 5.7 years and annual escalators averaging 3.0%. New leasing accounted for 350,000 square feet, contributing to a 25 basis point absorption in property occupancy, which reached 92.7% on a same-store basis. Tenant retention remained strong at 88.5%, supported by enhanced tenant satisfaction and a limited supply of new properties in outpatient medical markets. Cash leasing spreads averaged 4.8% year-to-date, benefiting from robust tenant demand and minimal competitive developments.
Healthcare Realty also engaged in strategic capital allocation, with joint venture acquisitions totaling $200 million ($40 million at the company's share), primarily targeting high-growth urban centers such as Seattle, Charleston, and Denver. These joint ventures are projected to deliver a 7.5% cash yield, proving accretive relative to the company’s implied capitalization rate of approximately 6%. Concurrently, $83 million in assets were divested at a blended cap rate below 5%, allowing for capital recycling into higher-yielding investments. Share repurchases amounted to $75 million in Q2, bringing the total to $175 million since the strategic plan’s inception. The company also issued $700 million in exchangeable senior notes at a 3% coupon to refinance existing debt and secured a $400 million delayed draw term loan, enhancing liquidity. These financial maneuvers have maintained the company’s Net Debt to Adjusted EBITDA at 5.6x, within its target mid-5x range. A significant $35 million investment is planned for the Ascension St. Thomas West Redevelopment, complementing a $120 million modernization by the health system, with an expected 9% to 12% cash-on-cash return. Additional transactions include a $16 million land sale in Denver to CommonSpirit and the $36 million sale of the Kennestone Cancer Center to Wellstar. Signed Not Occupied (SNO) leases represent 460,000 square feet, anticipating 140 basis points of future occupancy gains. Maintenance capital expenditures totaled $27.1 million, reflecting ongoing property improvements and leasing commissions, further demonstrating the company’s commitment to optimizing its portfolio.
The company's leadership expressed strong satisfaction with the initial year of the strategic plan, emphasizing the development of a results-oriented culture. The sustained outperformance across key metrics, coupled with a proactive approach to capital allocation and market dynamics, positions Healthcare Realty Trust as a leader in the medical office sector. This foundational success provides a clear pathway for continued growth and value creation in the coming years, reinforcing its ambition to define excellence in outpatient medical real estate.